Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) FCF Margin (2016 - 2020)

Historic FCF Margin for KalVista Pharmaceuticals (KALV) over the last 7 years, with Q2 2020 value amounting to 330.18%.

  • KalVista Pharmaceuticals' FCF Margin rose 384500.0% to 330.18% in Q2 2020 from the same period last year, while for Jan 2021 it was 424.58%, marking a year-over-year decrease of 582700.0%. This contributed to the annual value of 2651.72% for FY2025, which is 28309800.0% up from last year.
  • Per KalVista Pharmaceuticals' latest filing, its FCF Margin stood at 330.18% for Q2 2020, which was up 384500.0% from 831.26% recorded in Q1 2020.
  • In the past 5 years, KalVista Pharmaceuticals' FCF Margin ranged from a high of 1202.83% in Q1 2018 and a low of 75257.14% during Q1 2016
  • Over the past 5 years, KalVista Pharmaceuticals' median FCF Margin value was 368.63% (recorded in 2019), while the average stood at 5403.84%.
  • Per our database at Business Quant, KalVista Pharmaceuticals' FCF Margin plummeted by -148428600bps in 2016 and then surged by 57379100bps in 2018.
  • KalVista Pharmaceuticals' FCF Margin (Quarter) stood at 2134.01% in 2016, then skyrocketed by 70bps to 648.62% in 2017, then surged by 75bps to 161.07% in 2018, then dropped by -26bps to 202.24% in 2019, then tumbled by -63bps to 330.18% in 2020.
  • Its last three reported values are 330.18% in Q2 2020, 831.26% for Q1 2020, and 202.24% during Q4 2019.